Literature DB >> 23863715

Somitic disruption of GNAS in chick embryos mimics progressive osseous heteroplasia.

Dana M Cairns1, Robert J Pignolo, Tomoya Uchimura, Tracy A Brennan, Carter M Lindborg, Meiqi Xu, Frederick S Kaplan, Eileen M Shore, Li Zeng.   

Abstract

Progressive osseous heteroplasia (POH) is a rare developmental disorder of heterotopic ossification (HO) caused by heterozygous inactivating germline mutations in the paternal allele of the GNAS gene. Interestingly, POH lesions have a bewildering mosaic distribution. Using clinical, radiographic, and photographic documentation, we found that most of the 12 individuals studied had a lesional bias toward one side or the other, even showing exclusive sidedness. Most strikingly, all had a dermomyotomal distribution of HO lesions. We hypothesized that somatic mutations in a progenitor cell of somitic origin may act on a background of germline haploinsufficiency to cause loss of heterozygosity at the GNAS locus and lead to the unilateral distribution of POH lesions. Taking advantage of the chick system, we examined our hypothesis by mimicking loss of heterozygosity of GNAS expression using dominant-negative GNAS that was introduced into a subset of chick somites, the progenitors that give rise to dermis and muscle. We observed rapid ectopic cartilage and bone induction at the axial and lateral positions in a unilateral distribution corresponding to the injected somites, which suggests that blocking GNAS activity in a targeted population of progenitor cells can lead to mosaic ectopic ossification reminiscent of that seen in POH.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23863715      PMCID: PMC3726175          DOI: 10.1172/JCI69746

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

Review 1.  Molecular and cellular biology of avian somite development.

Authors:  F E Stockdale; W Nikovits; B Christ
Journal:  Dev Dyn       Date:  2000-11       Impact factor: 3.780

2.  Analysis of genomic imprinting of Gs alpha gene.

Authors:  Lee S Weinstein; Shuhua Yu; Jie Liu
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

3.  The chick transcriptional repressor Nkx3.2 acts downstream of Shh to promote BMP-dependent axial chondrogenesis.

Authors:  L C Murtaugh; L Zeng; J H Chyung; A B Lassar
Journal:  Dev Cell       Date:  2001-09       Impact factor: 12.270

Review 4.  Progressive osseous heteroplasia.

Authors:  F S Kaplan; E M Shore
Journal:  J Bone Miner Res       Date:  2000-11       Impact factor: 6.741

Review 5.  Relative functions of Gαs and its extra-large variant XLαs in the endocrine system.

Authors:  M Bastepe
Journal:  Horm Metab Res       Date:  2012-06-22       Impact factor: 2.936

Review 6.  The development of the avian vertebral column.

Authors:  B Christ; R Huang; J Wilting
Journal:  Anat Embryol (Berl)       Date:  2000-09

7.  Tissue-specific expression of antisense and sense transcripts at the imprinted Gnas locus.

Authors:  T Li; T H Vu; Z L Zeng; B T Nguyen; B E Hayward; D T Bonthron; J F Hu; A R Hoffman
Journal:  Genomics       Date:  2000-11-01       Impact factor: 5.736

8.  Smoothened mutants reveal redundant roles for Shh and Ihh signaling including regulation of L/R symmetry by the mouse node.

Authors:  X M Zhang; M Ramalho-Santos; A P McMahon
Journal:  Cell       Date:  2001-07-27       Impact factor: 41.582

9.  G protein signaling from activated rat frizzled-1 to the beta-catenin-Lef-Tcf pathway.

Authors:  T Liu; A J DeCostanzo; X Liu; S Hallagan; R T Moon; C C Malbon
Journal:  Science       Date:  2001-06-01       Impact factor: 47.728

10.  Genetic manipulation of hedgehog signaling in the endochondral skeleton reveals a direct role in the regulation of chondrocyte proliferation.

Authors:  F Long; X M Zhang; S Karp; Y Yang; A P McMahon
Journal:  Development       Date:  2001-12       Impact factor: 6.868

View more
  13 in total

Review 1.  Pseudohypoparathyroidism and Gsα-cAMP-linked disorders: current view and open issues.

Authors:  Giovanna Mantovani; Anna Spada; Francesca Marta Elli
Journal:  Nat Rev Endocrinol       Date:  2016-04-22       Impact factor: 43.330

Review 2.  GNAS Spectrum of Disorders.

Authors:  Serap Turan; Murat Bastepe
Journal:  Curr Osteoporos Rep       Date:  2015-06       Impact factor: 5.096

Review 3.  Heterotrimeric G proteins in the control of parathyroid hormone actions.

Authors:  Murat Bastepe; Serap Turan; Qing He
Journal:  J Mol Endocrinol       Date:  2017-05       Impact factor: 5.098

Review 4.  Conserved signaling pathways underlying heterotopic ossification.

Authors:  Chen Kan; Lijun Chen; Yangyang Hu; Na Ding; Haimei Lu; Yuyun Li; John A Kessler; Lixin Kan
Journal:  Bone       Date:  2017-04-25       Impact factor: 4.398

Review 5.  GNAS mutations and heterotopic ossification.

Authors:  Murat Bastepe
Journal:  Bone       Date:  2017-09-06       Impact factor: 4.398

Review 6.  GNAS mutations in Pseudohypoparathyroidism type 1a and related disorders.

Authors:  Manuel C Lemos; Rajesh V Thakker
Journal:  Hum Mutat       Date:  2014-11-28       Impact factor: 4.878

Review 7.  Progressive osseous heteroplasia: diagnosis, treatment, and prognosis.

Authors:  Robert J Pignolo; Girish Ramaswamy; John T Fong; Eileen M Shore; Frederick S Kaplan
Journal:  Appl Clin Genet       Date:  2015-01-30

Review 8.  Current Nomenclature of Pseudohypoparathyroidism: Inactivating Parathyroid Hormone/Parathyroid Hormone-Related Protein Signaling Disorder.

Authors:  Serap Turan
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-12-27

9.  Gsα Controls Cortical Bone Quality by Regulating Osteoclast Differentiation via cAMP/PKA and β-Catenin Pathways.

Authors:  Girish Ramaswamy; Hyunsoo Kim; Deyu Zhang; Vitali Lounev; Joy Y Wu; Yongwon Choi; Frederick S Kaplan; Robert J Pignolo; Eileen M Shore
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

Review 10.  Pseudohypoparathyroidism, acrodysostosis, progressive osseous heteroplasia: different names for the same spectrum of diseases?

Authors:  Francesca Marta Elli; Giovanna Mantovani
Journal:  Endocrine       Date:  2020-11-11       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.